Fish intake may limit the increase in risk of coronary heart disease morbidity and mortality among heavy smokers: The Honolulu Heart Program

Circulation

Volumn 94, Issue 5, 1996, Pages 952-956

  Rodriguez, Beatriz L ^a,b,e   Sharp, Dan S ^b   Abbott, Robert D ^a,c   Burchfiel, Cecil M ^b   Masaki, Kamal ^a   Chyou, Po Huang ^d   Huang, Boji ^a,d   Yano, Katsuhiko ^a,d   Curb, Jess David ^a,d  

^a UNIVERSITY OF HAWAII   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d KUAKINI MEDICAL CENTER   (United States)

^e Honolulu Heart Program   (United States)

Author keywords

coronary disease; epidemiology; fatty acids; follow up studies; smoking

Indexed keywords

ADULT; AGED; ARACHIDONIC ACID METABOLISM; ARTICLE; CORONARY ARTERY DISEASE; DIETARY INTAKE; FEMALE; FISH; GLUCOSE BLOOD LEVEL; HEART PROTECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK FACTOR; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 0029835158     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.5.952     Document Type: Article

References (39)

1. Sharp DS, Rodriguez BL, Shahar E, Huang LJ, Burchfiel CM. Fish consumption may limit the damage of smoking on the lung. Am J Respir Crit Care Med. 1994;150:983-987.
2. Sharp DS. Fish consumption may limit damage of smoking in the lung. Am J Respir Crit Care Med. 1995;151:1688-1689.
3. Shahar E, Folsom AR, Melnick SL, Tockman MS, Comstock GW, Gennaro V, Higgins MW, Sorlie PD, Ko WJ, Szklo M. Dietary n-3 polyunsaturated fatty acids and smoking-related chronic obstructive pulmonary disease. N Engl J Med. 1994;331:228-233.
4. Kromhout D, Bosschieter EB, Coulander CL. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med. 1985;312:1205-1209.
5. Shekelle RB, Missell LV, Paul O, Shryock AM, Stamler J. Fish consumption and mortality from coronary heart disease. N Engl J Med. 1985;313:820. Letter.
6. Norell SE, Ahlbom A, Feychtyng M, Pedersen NL. Fish consumption and mortality from coronary heart disease. Br Med J. 1986;293:426.
7. Kromhout D, Feskens EJ, Bowles CH. The protective effect of a small amount offish on coronary heart disease mortality in an elderly population. Int J Epidemiol. 1995;24:340-345.
8. Feskens EJ, Kromhout D. Epidemiologic studies on Eskimos and fish intake. Ann N Y Acad Sci. 1993;683:9-15.
9. Curb JD, Reed DM. Fish consumption and mortality from coronary heart disease. N Engl J Med. 1985;313:821. Letter.
10. Vollset SE, Heich I, Bjelke E. Fish consumption and mortality from coronary heart disease. N Engl J Med. 1985;313:820-821.
11. Ascherio A, Rimm EB, Stampfer MJ, Giovannucci EL, Willett WC. Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary heart disease among men. N Engl J Med. 1995;332:977-982.
12. Guallar E, Hennekens CH, Sacks FM, Willett WC, Stampfer MJ. A prospective study of plasma fish oil levels and incidence of myocardial infarction in US male physicians. J Am Coll Cardiol. 1995;25:387-394.
13. Burr ML, Gilbert JF, Holliday RM, Elwood PC, Fehily AM, Rogers S, Sweetnam PM, Deadman NM. Effects of changes in fat, fish, and fibre intakes on death and myocardial infarction: Diet And Reinfarction Trial (DART). Lancet. 1989;8666:757-761.
14. Bairati I, Roy L, Mayer F. Double-blind, randomized, controlled trial of fish supplements in prevention of recurrence of stenosis after coronary angioplasty. Circulation. 1992;85:950-956.
15. Gapinski JP, VanRuiswyk JV, Heudebert GR, Schectman GS. Preventing restenosis with fish oils following coronary angioplasty: a meta-analysis. Arch Intern Med. 1993;153:1595-1601.
16. Leaf A, Jorgensen MB, Jacobs AK, Cote G. Do fish oils prevent restenosis after coronary angioplasty? Circulation. 1994;90:2248-2257.
17. Franzen D, Schannwell M, Oette K, Hopp HW. A prospective, randomized, and double blind-trial on the effect of fish oil on the incidence of restenosis following PTCA. Cathel Cardiovasc Diagn. 1993;28:301-310.
18. Kagan A, Harris BR, Winkelstein W, Johnson KG, Kato H, Syme SL, Rhoads GG, Gay ML, Nichaman MZ, Hamilton HB, Tillotson JL. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: demographic, physical, dietary and biochemical characteristics. J Chron Dis. 1974;27:345-364.
19. Worth RM, Kagan A. Ascertainment of men of Japanese ancestry in Hawaii through World War II Selective Service registration. J Chron Dis. 1970;23:389-397.
20. Rhoads G, Kagan A, Yano K. Usefulness of community surveillance for the ascertainment of coronary heart disease and stroke. Int J Epidemiol. 1975;4:265-270.
21. Yano K, Reed DM, McGee DL. Ten-year incidence of coronary heart disease in the Honolulu Heart Program. Am J Epidemiol. 1984;119:653-666.
22. Oliver MF. Cigarette smoking, polyunsaturated fats, linoleic acid and coronary heart disease. Lancet. 1989;8649:1241-1242.
23. Leaf A, Weber PC. Cardiovascular effects of n-3 fatty acids. N Engl J Med. 1988;318:549-557.
24. Israel DH, Gorlin R. Fish oils in the prevention of atherosclerosis. J Am Coll Cardiol. 1992;19:174-185.
25. Simopoulos AP. Omega 3 fatty acids in health and disease and in growth and development. Am J Clin Nutr. 1991;54:438-463.
26. Kinsella JE, Lokesh B, Stone RA. Dietary n-3 polyunsaturated fatty acids and amelioration of cardiovascular disease: possible mechanisms. Am J Clin Nutr. 1990;52:1-28.
27. Phillipson BE, Rothrock DW, Connor WE, Harris WS, Illingworth DR. Reduction of plasma lipids, lipoproteins and apoproteins by di- etary fish oils in patients with hypertriglyceridemia. N Engl J Med. 1985;312:1210-1216.
28. Sanders TA. Fish consumption and coronary heart disease. Cardiovasc Risk Factors. 1991;1:307-312.
29. Hostmark AT, Bjerkedal T, Kierulf P, Platen H, Ulshagen K. Fish oil and plasma fibrinogen. Br Med J. 1988;297:180-181.
30. Saynor R, Gillott T. Fish oil and plasma fibrinogen. Br Med J. 1988;297:1196. Letter.
31. Tulleken JE, Limburg P, Van Rijswijk MH. Fish oil and plasma fibrinogen. Br Med J. 1988;297:615-616. Letter.
32. Gans ROB, Bilo HJG, Scheuten JA, Rauwerda JA. Fish oil and plasma fibrinogen. Br Med J. 1988;297:978-997. Letter.
33. Wilhelmsen L, Svardsudd K, Korsan-Bengtsenn K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984;311:501-505.
34. Kannel WB, D'Agostino RB, Belanger AJ. Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study. Am Heart J. 1987;113:1006-1010.
35. Terano T, Hirai A, Hamazaki T, Kobayashi S, Fujita T, Tamura Y, Kumagai A. Effect of oral administration of highly purified eicosapentaenoic acid on platelet function, blood viscosity and red cell deformability in healthy human subjects. Atherosclerosis. 1983;46:321-331.
36. Barcelli U, Glas-Greenwalt P, Pollak VE. Enhancing effect of dietary supplementation with omega-3 fatty acids on plasma fibrinolysis in normal subjects. Thromb Res. 1985;39:307-312.
37. Lorenz R, Spengler U, Fischer S, Duhm J, Weber PC. Platelet function, thromboxane formation and blood pressure control during supplementation of the western diet with cod liver oil. Circulation. 1983;67:504-511.
38. Singer P, Berger I, Luck K, Taube C, Naumann E, Godicke W. Long-term effect of mackerel diet on blood pressure, serum lipids and thromboxane formation in patients with mild essential hypertension. Atherosclerosis. 1986;62:259-265.
39. Fitzgerald GA, Braden G, Fitzgerald DJ, Knapp HR. Fish oils in cardiovascular disease. J Intern Med. 1989;225:25-29.